AngioSoma Inc

Company Snapshot
2500 Wilcrest Drive
Houston, TX 77042
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 1
https://www.angiosoma.com
Please select from the dropdown
  1. Executive Compensation
  2. > AngioSoma Inc
Company Financials

2019
2020
2021
Gross Profit
$271
-$37,605
-$2,412
Operating Income
-$315,870
-$303,671
-$9,094,229
Net Income
-$675,072
-$541,731
-$9,801,628
2019
Gross Profit
$271
Operating Income
-$315,870
Net Income
-$675,072
2020
Gross Profit
-$37,605
Operating Income
-$303,671
Net Income
-$541,731
2021
Gross Profit
-$2,412
Operating Income
-$9,094,229
Net Income
-$9,801,628
The above data on AngioSoma Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Robert Federowicz
Chairman of the Board, Interim Chief Executive Officer and President
$25,000
$0
$0
$25,000
Robert Federowicz
$25,000
Chairman of the Board, Interim Chief Executive Officer and President
AngioSoma Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2013. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us